Biofrontera Inc.
Biofrontera Inc. (BFRI) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bfri · stock forecast · 1 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.93
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.98 | ↑ 5.00% |
1-day model range: $0.97–$0.99. Peak: $0.99 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -35.9% |
| 2028 | $0 | -47.4% |
| 2029 | $0 | -52.2% |
| 2030 | $0 | -54.3% |
| 2031 | — | -55.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BFRI · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-19 | Benchmark | Maintains | Buy→Speculative Buy |
| 2025-05-19 | Benchmark | Maintains | Buy→Buy |
| 2024-11-15 | Benchmark | Maintains | Buy→Buy |
| 2024-08-16 | Benchmark | Maintains | Buy→Buy |
| 2023-08-31 | Benchmark | Maintains | Buy→Buy |
| 2023-07-05 | Benchmark | Maintains | Buy→Buy |
| 2023-05-15 | Benchmark | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Biofrontera Inc. (BFRI) stock. Of the recent 7 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover BFRI.
Analyst Recommendation Trends
BFRI analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$46M
↓ 29.1% YoY
Revenue Next Year
$53M
↑ 15.4% YoY
EPS This Year
$-0.23
EPS Next Year
$0.19
↓ 182.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast BFRI EPS of $-0.23 for the current fiscal year, based on estimates from 1 analysts. The BFRI revenue forecast is $46M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BFRI stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BFRI price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The BFRI short-term stock prediction for tomorrow is $0.98 (+5.00%). The BFRI stock price prediction for 2027 estimates an average of $1. The BFRI stock prediction for 2030 projects a range of $0–$0.
Biofrontera Inc. trades on NASDAQ under the ticker BFRI. The BFRI stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
BFRI forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month BFRI price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $0.93.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.